Pisa syndrome in a cohort of Alzheimer's disease patients.
Three Alzheimer's disease patients with Pisa syndrome were presented. These patients were treated with cholinesterase inhibitors within a post-marketing surveillance study. The clinical and pharmacological histories of these patients suggest a relation between cholinesterase inhibitors and the pleurothotonus. The diffuse use of cholinesterase inhibitors in the treatment of dementia may cause an increasing number of Pisa syndrome cases.
Vanacore
N
N
National Centre of Epidemiology, National Institute of Health, Rome, Italy. nicola.vanacore@iss.it
Suzzareddu
G
G
Maggini
M
M
Casula
A
A
Capelli
P
P
Raschetti
R
R
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D004421:Dystonia / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D006801:Humans; D015994:Incidence; D013577:Syndrome
D002800:Cholinesterase Inhibitors